thiazoles has been researched along with abt-737 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, Y; Wu, XM; Zhang, DY | 1 |
| Beaumont, T; Breij, EC; Eldering, E; Elias, JA; Geest, CR; Kater, AP; Luijks, DM; Tromp, JM; van Laar, J; van Oers, MH | 1 |
| Adams, VC; Ahearne, MJ; Beck, D; Wagner, SD; Willimott, S | 1 |
| Cutts, SM; Green, MM; Hawkins, CJ; Miles, MA; Rayner, DM; Shekhar, TM | 1 |
| Albericio, F; Cosialls, AM; Gil, J; Iglesias-Serret, D; Lavilla, R; Noisier, AFM; Núñez-Vázquez, S; Pons, G; Sánchez-Vera, I; Saura-Esteller, J | 1 |
1 review(s) available for thiazoles and abt-737
| Article | Year |
|---|---|
[Progress in small-molecule inhibitors of Bcl-2 family proteins].
Topics: Antimycin A; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Drug Design; Drugs, Chinese Herbal; Gossypol; Humans; Nitriles; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Sulfonamides; Thiazoles; Thiazolidinediones | 2008 |
4 other study(ies) available for thiazoles and abt-737
| Article | Year |
|---|---|
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Biphenyl Compounds; CD40 Antigens; CD40 Ligand; Coculture Techniques; Dasatinib; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Mice; Middle Aged; Minor Histocompatibility Antigens; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; NIH 3T3 Cells; Nitrophenols; p38 Mitogen-Activated Protein Kinases; Piperazines; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Signal Transduction; Sulfonamides; Thiazoles; Tumor Cells, Cultured; Vidarabine | 2012 |
Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Neoplasm; Elafin; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrazones; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nitro Compounds; Nitrophenols; Piperazines; Protein Biosynthesis; Sulfonamides; Thiazoles | 2013 |
Inhibition of Bcl-2 or IAP proteins does not provoke mutations in surviving cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azocines; bcl-2-Associated X Protein; Benzhydryl Compounds; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Inhibitor of Apoptosis Proteins; Mice; Mutagens; Mutation; Nitrophenols; Piperazines; Sulfonamides; Thiazoles | 2015 |
NOXA upregulation by the prohibitin-binding compound fluorizoline is transcriptionally regulated by integrated stress response-induced ATF3 and ATF4.
Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hydrocarbons, Fluorinated; Nitrophenols; Piperazines; Prohibitins; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thiazoles; Transcriptional Activation; Up-Regulation | 2021 |